129 related articles for article (PubMed ID: 1132601)
1. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
Ganda OP; Kahn CB; Soeldner JS; Gleason RE
Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
[TBL] [Abstract][Full Text] [Related]
2. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
[TBL] [Abstract][Full Text] [Related]
3. Craniopharyngioma: the role of insulin in promoting postoperative growth.
Costin G; Kogut MD; Phillips LS; Daughaday WH
J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
Pelkonen R; Kallio H; Suoranta H; Karonen SL
Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
[TBL] [Abstract][Full Text] [Related]
5. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
[TBL] [Abstract][Full Text] [Related]
6. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
7. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
8. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
Adamson U; Cerasi E
Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
[TBL] [Abstract][Full Text] [Related]
9. A drug interaction study between cicletanine and tolbutamide in healthy volunteers.
Bayés MC; Barbanoj MJ; Vallès J; Torrent J; Obach R; Jané F
Eur J Clin Pharmacol; 1996; 50(5):381-4. PubMed ID: 8839660
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose and some oral hypoglycemic agents upon the plasma glucose and immuno-reactive insulin (IRI) in normal and streptozotocin induced diabetic rat.
Kaul CL; Talwalker PK; Grewal RS
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):139-44. PubMed ID: 708137
[TBL] [Abstract][Full Text] [Related]
11. Insulinopenia in impaired glucose tolerance preservation of insulin response to I.V. arginine and tolbutamide.
Monson JP; Borthwick LJ; Spathis GS; Bloom SR
Acta Diabetol Lat; 1980; 17(1):1-7. PubMed ID: 6998240
[TBL] [Abstract][Full Text] [Related]
12. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
13. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
[TBL] [Abstract][Full Text] [Related]
14. Monozygotic triplets with discordance for diabetes mellitus and diabetic microangiopathy.
Ganda OP; Soeldner JS; Gleason RE; Smith TM; Kilo C; Williamson JR
Diabetes; 1977 May; 26(5):469-79. PubMed ID: 192616
[TBL] [Abstract][Full Text] [Related]
15. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
Boden G; Soeldner JS; Gleason RE; Marble A
J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
Costin G; Kogut MD; Hyman C; Ortega JA
Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretory responses in patients with glucose intolerance due to extra-pancreatic causes. Comparison with idiopathic diabetes mellitus.
Kosaka K; Kuzuya T; Hagura R; Akanuma Y; Kanazawa Y
Endocrinol Jpn; 1981 Aug; 28(4):487-98. PubMed ID: 6763894
[TBL] [Abstract][Full Text] [Related]
19. Glucoregulatory disorders in school refusal students.
Iwatani N; Miike T; Kai Y; Kodama M; Mabe H; Tomoda A; Fukuda K; Jyodoi T
Clin Endocrinol (Oxf); 1997 Sep; 47(3):273-8. PubMed ID: 9373447
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
Berchtold P; Büber V; Meier V; Felber JP; Keiser G
Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
